Tumeric Capital, the Singapore-based private equity firm led by former L Catterton Asia head Ravi Thakran, is said to be exploring listing a special purpose acquisition company (SPAC) in Singapore, according to a Bloomberg report.
Continue reading this premium story with a subscription to DealStreetAsia.
SubscribeAlready a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com